Hypersensitivity

31
HYPERSENSITIVITY AND ITS TYPES

description

hypersensitivity,hypersensitivity, pathophysiology, pathology, pharmd, vels, hypersensitivity reactions, immunoglobulin e, immunoglobulin g, hypersensitivity types

Transcript of Hypersensitivity

Page 1: Hypersensitivity

HYPERSENSITIVITYAND ITS TYPES

Page 2: Hypersensitivity

HYPERSENSITIVITY

Hypersensitivity  refers to undesirable reactions produced by the normal immune system, including  allergies and autoimmunity

These reactions may be damaging, uncomfortable, or occasionally fatal.

Page 3: Hypersensitivity

CLASSIFICATION

TYPE I – IMMEDIATE, ATOPIC, ANAPHYLACTIC

TYPE II – ANTIBODY DEPENDANT TYPE III – IMMUNE COMPLEX TYPE IV – CELL MEDIATED / DELAYED

TYPE OF HYPERSENSITIVITY

Page 4: Hypersensitivity

TYPE I. IMMEDIATE OR ANAPHYLACTIC HYPERSENSITIVITY

Type I hypersensitivity is also known as immediate or anaphylactic hypersensitivity.

The reaction may involve skin (urticariaand eczema), eyes (conjunctivitis), nasopharynx (rhinorrhea, rhinitis), bronchopulmonary tissues (asthma) and gastrointestinal tract (gastroenteritis).

Page 5: Hypersensitivity

TYPE I. IMMEDIATE OR ANAPHYLACTIC HYPERSENSITIVITY

The reaction may cause a range of symptoms from minor inconvenience to death.

The reaction usually takes 15 - 30 minutes from the time of exposure to the antigen, although sometimes it may have a delayed onset (10 - 12 hours).

Page 6: Hypersensitivity

TYPE I. IMMEDIATE OR ANAPHYLACTIC HYPERSENSITIVITY

Mediated by IgE antibody to specific antigens

The primary cellular component in this hypersensitivity is the mast cell or basophil.

The reaction is amplified and/or modified by platelets, neutrophils and eosinophils.

Mast cells stimulated and release histamine

Page 7: Hypersensitivity

CAUSES

ALLERGEN:Allergens are nonparasite antigens that can stimulate a type I hypersensitivity response.

Page 8: Hypersensitivity

Atopy

Atopy is the term for the genetic trait to have a predisposition for localized anaphylaxis.

Atopic individuals have higher levels of IgE and eosinophils.

Page 9: Hypersensitivity

MECHANISM

Initial introduction of antigen produces an antibody response. More specifically, the type of antigen and the way in which it is administered induce the synthesis of IgE antibody in particular.

Immunoglobulin IgE binds very specifically to receptors on the surface of mast cells, which remain circulating.

Page 10: Hypersensitivity

MECHANISM

Reintroduced antigen interacts with IgE on mast cells causing the cells to degranulate and release large amounts of histamine, lipid mediators and chemotactic factors that cause smooth muscle contraction, vasodilation, increased vascular permeability, broncoconstriction and edema. These reactions occur very suddenly, causing death.

Page 11: Hypersensitivity

MEDIATORS OF TYPE 1

Histamine Cytokines TNF-a, IL-1, IL-6. Chemoattractants for Neutrophils and Eosinophils. Enzymes

tryptase, chymase, cathepsin. Changes in connective tissue matrix, tissue

breakdown Leukotrienes Prostaglandins

Page 12: Hypersensitivity
Page 13: Hypersensitivity

DIAGNOSIS Diagnostic tests for immediate

hypersensitivity include skin (prick and intradermal) tests , measurement of total IgE and specific IgE antibodies against the suspected allergens.

Total IgE and specific IgE antibodies are measured by a modification of enzyme immunoassay (ELISA).

Increased IgE levels are indicative of an  atopic condition, although IgE may be elevated in some non-atopic diseases (e.g., myelomas, helminthic infection, etc.).

Page 14: Hypersensitivity

TREATMENT Drugs.

› Non-steroidal anti-inflammatories › Antihistamines block histamine receptors.› Steroids› Theophylline OR epinephrine -prolongs or increases

cAMP levels in mast cells which inhibits degranulation. Immunotherapy

› Desensitization (hyposensitization) also known as allergy shots.

› Repeated injections of allergen to reduce the IgE on Mast cells and produce IgG.

Page 15: Hypersensitivity

TYPE II HYPERSENSITIVITY

Type II hypersensitivity is also known as cytotoxic hypersensitivity and may affect a variety of organs and tissues.

The antigens are normally endogenous, although exogenous chemicals (haptens) which can attach to cell membranes can also lead to type II hypersensitivity.

Drug-induced hemolytic anemia, granulocytopenia and thrombocytopenia are such examples. Pencillin allergy also belong to this class.

Page 16: Hypersensitivity

TYPE II HYPERSENSITIVITY

The reaction time is minutes to hours. Type II hypersensitivity is primarily

mediated by antibodies of the IgM or IgG classes and complement .

Phagocytes may also play a role. The lesion contains antibody,

complement and neutrophils.

Page 17: Hypersensitivity

Hemolytic disease of newborn

Rh factor incompatibility IgG abs to Rh an innocuous rbc antigen

› Rh+ baby born to Rh- mother first time fine. 2nd time can have abs to Rh from 1st pregnancy.

› Ab crosses placenta and baby kills its own rbcs. › Treat mother with ab to Rh antigen right after birth

and mother never makes its own immune response.

Page 18: Hypersensitivity
Page 19: Hypersensitivity

DIAGNOSIS

Diagnostic tests include detection of circulating antibody against the tissues involved and the presence of antibody and complement in the lesion (biopsy) by immunofluorescence.

The staining pattern is normally smooth and linear, such as that seen in Goodpasture's nephritis (renal and lung basement membrane)

Treatment involves anti-inflammatory and immunosuppressive agents

Page 20: Hypersensitivity

TYPE III

Antigen antibody immune complexes. IgG mediated

Large amount of antigen and antibodies form complexes in blood.

If not eliminated can deposit in capillaries or joints and trigger inflammation.

Page 21: Hypersensitivity

TYPE III

The reaction may be general (e.g., serum sickness) or may involve individual organs including skin (e.g., systemic lupus erythematosus, Arthus reaction), kidneys (e.g., lupus nephritis), lungs (e.g., aspergillosis), joints (e.g., rheumatoid arthritis) or other organs.

This reaction may be the pathogenic mechanism of diseases caused by many microorganisms.

Page 22: Hypersensitivity

TYPE III

The reaction may take 3 - 10 hours after exposure to the antigen .

It is mediated by soluble immune complexes. They are mostly of the IgG class, although IgM

may also be involved. The antigen may be exogenous (chronic

bacterial, viral or parasitic infections), or endogenous (non-organ specific autoimmunity: e.g., systemic lupus erythematosus, SLE).

The antigen is soluble and not attached to the organ involved

Page 23: Hypersensitivity

TYPE III

PMNs and macrophages bind to immune complexes via FcR and phagocytize the complexes.

BUT If unable to phagocytize the immune

complexes can cause inflammation via C’ activation ---> C3a C4a, C5a and "frustrated phagocytes".

Page 24: Hypersensitivity

DIAGNOSIS AND TREATMENT

Diagnosis involves examination of tissue biopsies for deposits of immunoglobulin and complement by immunofluorescence microscopy.

The presence of immune complexes in serum and depletion in the level of complement are also diagnostic.

Treatment includes anti-inflammatory agents.

Page 25: Hypersensitivity

TYPE IV DELAYED TYPE

Reaction involves sensitized T cells and release of

its lymphokines as mediators and amplifiers

Mediated by cells rather than antibodies

Clinical states: Contact dermatitis, , Transplant rejection, Granuloma

Page 26: Hypersensitivity

TYPE IV

Th1 cells release cytokines to activate macrophages causing inflammation and tissue damage.

Continued macrophage activation can cause chronic inflammation resulting in tissue lesions, scarring, and granuloma formation.

Response starts after 48 -72 hrs

Page 27: Hypersensitivity

 Delayed hypersensitivity reactions

Type Reaction time

Clinical appearance Histology Antigen and

site

Contact dermatitis 48-72 hr eczema

lymphocytes, followed by macrophages; edema of epidermis

epidermal ( organic chemicals, poison ivy, heavy metals, etc.)

tuberculin 48-72 hr local induration

lymphocytes, monocytes, macrophages

intradermal (tuberculin, lepromin, etc.)

granuloma 21-28 days hardening

macrophages, epitheloid and giant cells, fibrosis

persistent antigen or foreign body presence (tuberculosis, leprosy, etc.)

Page 28: Hypersensitivity

DIAGNOSIS AND TREATMENT

Diagnostic tests in vivo include delayed cutaneous reaction (e.g. Montoux test and patch test (for contact dermatitis).

In vitro tests for delayed hypersensitivity include mitogenic response, lympho-cytotoxicity and IL-2 production.

Corticosteroids and other immunosuppressive agents are used in treatment.

 

Page 29: Hypersensitivity

Comparison of Different Types of hypersensitivity

characteristics

type-Ianaphylactic

type-II(cytotoxic)

type-III(immune complex)

type-IV(delayed type)

antibody IgE IgG, IgM IgG, IgM None

antigen exogenous cell surface soluble tissues & organs

response time

15-30 minutes minutes-hours 3-8 hours 48-72 hours

appearance weal & flare lysis and

necrosiserythema and edema, necrosis

erythema and induration

histology basophils and eosinophil

antibody and complement

complement and neutrophils

monocytes and lymphocytes

transferred with antibody antibody antibody T-cells

examplesallergic asthma, hay fever

erythroblastosisfetalis, Goodpasture's nephritis

SLE, farmer's lung disease 

tuberculin test, poison ivy, granuloma

Page 30: Hypersensitivity
Page 31: Hypersensitivity